APLS   $31.435  -14.39% Market Open

Apellis Pharmaceuticals Inc
Total Cash 368.04M
totalCashPerShare 3.023
EBITDA -311.30M
Total Debt 474.51M
quickRatio 4.001
currentRatio 5.084
Total Revenue 628.79M
debtToEquity 179.516
Revenue/Share 5.15
ROA -0.21506001
ROE -1.09194
grossProfits
freeCashflow -336.11M
operatingCashflow -408.28M
earningsGrowth
revenueGrowth 1.103
grossMargins 0.36865002
ebitdaMargins -0.49508
operatingMargins -0.14745
profitMargins -0.52942
enterpriseValue 4.69B
forwardPE 357.09998
floatShares 81.84M
sharesOutstanding 121.77M
sharesShort 16.17M
sharesShortPriorMonth 15.92M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.14%
heldPercentInstitutions 0.97%
Short Ratio help_outline 10.78%
shortPercentOfFloat 0.18%
impliedSharesOutstanding
bookValue 2.172
Price To Book help_outline 16.44
earningsQuarterlyGrowth
netIncomeToCommon -332.89M
trailingEps -2.72%
forwardEps 0.10%
enterpriseToEbitda -15.06
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.29 3Q 2024
institutionsCount 383
lastUpdated Sept. 16, 2024, 4:41 p.m.